Home › Lymphoma › California › Santa Monica
Lymphoma clinical trials in Santa Monica, CA
3 studies for Lymphoma are looking for participants at sites in and around Santa Monica (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
RecruitingPhase 3
- University of California Los Angeles (UCLA) - Cancer Care - Santa Monica, Santa Monica
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RecruitingPhase 1/2
- Providence St. John's Health Center, Santa Monica
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
RecruitingPhase 1/2
- Sarcoma Oncology Research Center, Santa Monica
About Lymphoma
Lymphoma is a cancer affecting the immune system. Hodgkins Lymphoma and Non Hodgkins Lymphoma are types of lymphoma. Learn about symptoms and treatments.
More about Lymphoma on MedlinePlus
Lymphoma trials in other cities
- Houston, TX34 studies
- Boston, MA34 studies
- New York City, NY33 studies
- Washington, DC23 studies
- Baldwin Park, CA22 studies
- Chicago, IL19 studies
- Durham, NC17 studies
- St. Louis, MO15 studies
- Cleveland, OH13 studies
- Seattle, WA13 studies
- Atlanta, GA13 studies
- Philadelphia, PA13 studies
Other studies in Santa Monica
- Non-Small Cell Lung Cancer45 studies
- Breast Cancer29 studies
- Cancer (all types)21 studies
- Colorectal Cancer20 studies
- Metastatic Cancer17 studies
- Prostate Cancer15 studies
- Ovarian Cancer14 studies
- Lung Cancer14 studies
- Head and Neck Squamous Cell Carcinoma12 studies
- Heart Failure10 studies
- Pancreatic Cancer9 studies
- Liver Cancer (Hepatocellular Carcinoma)9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.